carmofur and epirubicin

carmofur has been researched along with epirubicin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, T; Kohno, H; Nagasue, N; Ono, T; Uchida, M; Yamanoi, A; Yukaya, H1
Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Yang, YS1
Kohno, H; Nagasue, N; Nazmy El Assal, O; Ono, T; Yamanoi, A1

Reviews

1 review(s) available for carmofur and epirubicin

ArticleYear
Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.
    Cancer, 2001, Jun-15, Volume: 91, Issue:12

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Epirubicin; Female; Fluorouracil; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tegafur; Treatment Outcome

2001

Trials

1 trial(s) available for carmofur and epirubicin

ArticleYear
Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study.
    Seminars in oncology, 1997, Volume: 24, Issue:2 Suppl 6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate

1997

Other Studies

1 other study(ies) available for carmofur and epirubicin

ArticleYear
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
    Journal of Korean medical science, 2001, Volume: 16, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Brain; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Nervous System Diseases; Prednisolone; Radiography

2001